News of Note—GlaxoSmithKline, VLP Therapeutics and more


Here is some other vaccine news of note for the week:

> GlaxoSmithKline's vaccine sales grew 16% last year to £5.9 billion ($7.64 billion). Shingrix sales hit £784 million ($1 billion) in its first full year on the market. Release

> Gaithersburg, Maryland-based VLP Therapeutics said it plans to kick off an initial clinical study of its malaria vaccine candidate. Release

> Officials in Kentucky are looking into vaccine-associated infections in Kentucky, Ohio and Indiana due to possible improper handling and storage by a service provider. Release (PDF)